title: Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Campiotti
authors.forename: Romeo
authors.initials: R
authors.lastname: Codari
authors.forename: Lorena
authors.initials: L
authors.lastname: Appio
authors.forename: Carolina
authors.initials: C
authors.lastname: Ultori
authors.forename: Francesco
authors.initials: F
authors.lastname: Solbiati
authors.forename: Anna
authors.initials: A
authors.lastname: Maria Grandi
authors.forename: Achille
authors.initials: A
authors.lastname: Venco
mesh_terms: D000368:Aged; D001549:Benzamides; D001752:Blast Crisis; D001855:Bone Marrow Diseases / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009336:Necrosis / Q000139:chemically induced; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate